Literature DB >> 1097637

The relationship between nitro group reduction and the intestinal microflora.

L A Wheeler, F B Soderberg, P Goldman.   

Abstract

The capacity of rats to reduce a 25-mg dose of p-nitrobenzoic acid (PNBA) was measured by quantifying the amount of this compound recovered in the urine as p-aminobenzoic acid (PABA) and its conjugates. It was found that germfree rats converted approximately 1% of PNBA to PABA; in conventional rats the conversion was approximately 25%. Various bacteria isolated from the rat cecum were selectively associated with germfree rats and it was demonstrated that these bacteria colonized their gastrointestinal tracts. In assoication with Lactobacillus plantarum, the conversion of PNBA to PABA increased to 3.9%. When these rats were further associated with Clostridium sp. and Streptoccocus faecalis, the conversion increased to approximately 12%. A general correlation was found between the capacity of constituents of the microflora to reduce PNBA in vitro and when associated with the germfree rat. Cecectomy, which removes a substantial portion of the microflora of the rat, decreases the capacity of the conventional rat to reduce PNBA. Similar experiments with p-nitrobenzenesulfonamide indicate that this compound is also largely reduced by the flora. Evidence that the reduction of the nitro group in these compounds is carried out by the intestinal microflora explains previous observations in which the reduction of these compounds in rats did not correlate with the activity of liver enzymes putative for these reactions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097637

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Association of salmonella mutants with germfree rats: site specific model to detect carcinogens as mutagens.

Authors:  L A Wheeler; J H Carter; F B Soderberg; P Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

2.  The importance of the intestinal microflora in nitrazepam metabolism in the rat [proceedings].

Authors:  D S Hewick; V Shaw
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

3.  Active metabolites of acenocoumarol: do they contribute to the therapeutic effect?

Authors:  H H Thijssen; L G Baars
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

4.  Reduction of polymeric azo and nitro dyes by intestinal bacteria.

Authors:  J P Brown
Journal:  Appl Environ Microbiol       Date:  1981-05       Impact factor: 4.792

5.  Synthesis and antibiotic properties of chloramphenicol reduction products.

Authors:  M D Corbett; B R Chipko
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

6.  Positron Emission Tomography Imaging of Staphylococcus aureus Infection Using a Nitro-Prodrug Analogue of 2-[18F]F-p-Aminobenzoic Acid.

Authors:  Yong Li; Fereidoon Daryaee; Grace E Yoon; Doyoung Noh; Peter M Smith-Jones; Yuanyuan Si; Stephen G Walker; Nashaat Turkman; Labros Meimetis; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2020-07-31       Impact factor: 5.084

7.  The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit.

Authors:  W Homsy; G Caillé; P du Souich
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

8.  Lack of presystemic metabolism of nifedipine in the rabbit.

Authors:  P du Souich; L Héroux; H Maurice; M Dépôt; G Caillé
Journal:  J Pharmacokinet Biopharm       Date:  1995-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.